Huang Ting, Yang Shi-qing, Gao Na, Wang Yu-juan
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.
Zhonghua Yan Ke Za Zhi. 2010 Sep;46(9):775-80.
To investigate the efficacy and complications of limbal allografting from related live donors (RL-LAT) for limbal stem cell deficiency secondary to ocular chemical burn.
Retrospective comparative case series. Limbal allografting from related live human leukocyte antigen (HLA)-matched (n = 10) and-unmatched donors (n = 2) was performed in 12 consecutive patients (12 eyes) with limbal stem cell deficiency secondary to ocular chemical burn, including 9 alkali burn and 3 acid burn; whereas allolimbal cadaver transplant was performed in another 15 patients in Zhongshan Ophthalmic Center between April 2006 to December 2007. Systemic cyclosporine A was administered to later eight recipients in living related donor group and all patients in cadaver donor group. Main outcome measures were restoration of corneal epithelium, reduction in corneal vascularization, improved corneal clarity, and visual improvement. Mean follow-up was (11.4 ± 3.6) months (from 12 to 27).
In living related donor group, ten patients (83.3%) achieved initially reepithelialize, and epithelial healing time was (9.6 ± 3.4) d. Nine patients (75.0%) achieved stable ocular surface (stable corneal epithelium, decreased vascularization of corneal surface, and reduced corneal opacification). However, in seven eyes (77.8%) achieved stable ocular surface, gradual recurrence of peripheral corneal vascularization occurred after 5 to 8 months postoperatively. Whereas in cadaver donor group, twelve patients (80.0%) achieved initially reepithelialize, and epithelial healing time was (11.2 ± 4.6) d. Seven patients (46.7%) achieved stable ocular surface. However, in all seven eyes achieved stable ocular surface, gradual recurrence of peripheral corneal vascularization occurred after 4 to 10 months postoperatively. The differences of both the rate of initially reepithelialize and epithelial healing time between these two groups showed no statistical significance (χ(2) = 1.764, P = 0.117; t = 0.116, P = 0.133, respectively). However, the differences of both the successful rate of ocular surface reconstruction and the recurrent rate of corneal vascularization during the follow-up period between these two groups were statistically significant (χ(2) = 4.158, P = 0.015; χ(2) = 3.463, P = 0.022, respectively). In living related donor group, features of graft rejection developed in two patients with postoperative stable ocular surface, Both rejected recipients had one among HLA-matched and one among-unmatched respectively. Whereas in cadaver donor group, features of graft rejection developed in three patients with postoperative stable ocular surface. None of the donor eyes had any complications.
Limbal allografting from related live donors is more effective to reconstruct the ocular surface of limbal stem cell deficiency secondary to ocular chemical burn than allolimbal cadaver transplant. HLA-matched limbal allografting could reduce postoperative graft rejection and systemic cyclosporine A is useful in ensuring long-term survival.
探讨来自相关活体供者的角膜缘移植术(RL-LAT)治疗眼部化学伤继发角膜缘干细胞缺乏症的疗效及并发症。
回顾性比较病例系列研究。对12例(12眼)眼部化学伤继发角膜缘干细胞缺乏症患者进行了来自相关活体人类白细胞抗原(HLA)配型相合(n = 10)和不相合供者(n = 2)的角膜缘移植术,其中碱烧伤9例,酸烧伤3例;而2006年4月至2007年12月期间,中山大学眼科中心对另外15例患者进行了异体角膜缘尸体移植。对活体亲属供体组的后8例受者及尸体供体组的所有患者均给予全身环孢素A治疗。主要观察指标为角膜上皮修复、角膜新生血管减少、角膜透明度改善及视力提高。平均随访时间为(11.4±3.6)个月(12至27个月)。
在活体亲属供体组中,10例患者(83.3%)实现了初始上皮化,上皮愈合时间为(9.6±3.4)天。9例患者(75.0%)实现了眼表稳定(角膜上皮稳定、角膜表面新生血管减少及角膜混浊减轻)。然而,在7只眼(77.8%)实现眼表稳定后,术后5至8个月周边角膜新生血管逐渐复发。而在尸体供体组中,12例患者(80.0%)实现了初始上皮化,上皮愈合时间为(11.2±4.6)天。7例患者(46.7%)实现了眼表稳定。然而,在所有7只实现眼表稳定的眼中,术后4至10个月周边角膜新生血管逐渐复发。两组间初始上皮化率及上皮愈合时间的差异均无统计学意义(χ(2)=1.764,P = 0.117;t = 0.116,P = 0.133)。然而,两组间随访期间眼表重建成功率及角膜新生血管复发率的差异均有统计学意义(χ(2)=4.158,P = 0.015;χ(2)=3.463,P = 0.022)。在活体亲属供体组中,2例术后眼表稳定的患者出现了移植物排斥反应特征,2例排斥受者分别有1例HLA配型相合和1例不相合。而在尸体供体组中,3例术后眼表稳定的患者出现了移植物排斥反应特征。供体眼均未出现任何并发症。
与异体角膜缘尸体移植相比,来自相关活体供者的角膜缘移植术在重建眼部化学伤继发角膜缘干细胞缺乏症的眼表方面更有效。HLA配型相合的角膜缘移植可减少术后移植物排斥反应,全身应用环孢素A有助于确保长期存活。